- The 61st Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO)
-
Yoshihara , Sekine M, Nishino K, Enomoto T
- KMID: 2458910
- J Gynecol Oncol.
- 2019 Nov;30(6):e114.
- doi: 10.3802/jgo.2019.30.e114
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
-
Machida H, Matsuo K, Enomoto T, Mikami M
- KMID: 2458909
- J Gynecol Oncol.
- 2019 Nov;30(6):e113.
- doi: 10.3802/jgo.2019.30.e113
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Trachelectomy for stage IB1 cervical cancer with tumor size >2 cm: trends and characteristics in the United States
-
Matsuo K, Machida H, Mandelbaum RS, Mikami M, Enomoto T, Roman LD, Wright JD
- KMID: 2431231
- J Gynecol Oncol.
- 2018 Nov;29(6):e85.
- doi: 10.3802/jgo.2018.29.e85
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Carboplatin and paclitaxel as an initial treatment in patients with stage IVb cervical cancer: a report of 7 cases and a review of the literature
-
Mabuchi S, Morishige , Enomoto T, Kimura T
- KMID: 2009577
- J Gynecol Oncol.
- 2010 Jun;21(2):93-96.
- doi: 10.3802/jgo.2010.21.2.93
OBJECTIVE: The aim of this study is to evaluate the efficacy of carboplatin-paclitaxel (TC) as an initial treatment in patients with the International Federation of Gynecology and Obstetrics (FIGO) stage... -
- CITED
-
- Close
- SHARE
-
- Close
- The use of conization to identify and treat severe lesions among prediagnosed CIN1 and 2 patients in Japan
-
Mikami M, Ikeda M, Sato H, Iwase H, Enomoto T, Kobayashi , Katabuchi
- KMID: 2417436
- J Gynecol Oncol.
- 2018 Jul;29(4):e46.
- doi: 10.3802/jgo.2018.29.e46
OBJECTIVE: To evaluate the clinical efficiency of identifying patients with suspicious severe lesions by conization among prediagnosed cervical intraepithelial neoplasia (CIN) 1 and 2 patients in Japan. METHODS: The data in... -
- CITED
-
- Close
- SHARE
-
- Close
- Potential Applicability of Local Resection With Prophylactic Left Gastric Artery Basin Dissection for Early-Stage Gastric Cancer in the Upper Third of the Stomach
-
Akashi Y, Ogawa K, Hisakura K, Enomoto T, Ohara Y, Owada Y, Hashimoto S, Takahashi K, Shimomura O, Doi M, Miyazaki Y, Furuya K, Moue S, Oda T
- KMID: 2535099
- J Gastric Cancer.
- 2022 Jul;22(3):184-196.
- doi: 10.5230/jgc.2022.22.e17
Purpose: Total or proximal gastrectomy of the upper-third early gastric cancer (u-EGC) often causes severe post-gastrectomy syndrome, suggesting that these procedures are extremely invasive for patients without pathologically positive lymph... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of menopause, aging and treatment procedures with positive margins after therapeutic cervical conization for CIN 3: a retrospective study of 8,856 patients by the Japan Society of Obstetrics and Gynecology
-
Ikeda M, Mikami M, Yasaka M, Enomoto T, Kobayashi Y, Nagase S, Yokoyama N, Katabuchi H
- KMID: 2526134
- J Gynecol Oncol.
- 2021 Sep;32(5):e68.
- doi: 10.3802/jgo.2021.32.e68
Objective The Japan Society of Obstetrics and Gynecology conducted a retrospective multi-institutional survey of patients who underwent cervical conization in Japan. This study aimed to determine the predictive factors for positive... -
- CITED
-
- Close
- SHARE
-
- Close
- Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy
-
Sekine M, Enomoto T, Arai M, Den H, Nomura H, Ikeuchi T, Nakamura S, the Registration Committee of the Japanese Organization of Hereditary Breast and Ovarian Cancer
- KMID: 2537893
- J Gynecol Oncol.
- 2022 Jul;33(4):e46.
- doi: 10.3802/jgo.2022.33.e46
Objective BRCA1 and BRCA2 mutation carriers are recommended to undergo risk-reducing salpingo-oophorectomy (RRSO) by age 40 and 45, respectively. However, the carriers have a different way of thinking about their life... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of colonic metaplasia of goblet cells and endoscopic phenotypes of the J pouch in patients with ulcerative colitis: a retrospective pilot study
-
Akiyama S, Onoda T, Moue S, Sakamoto N, Sakamoto T, Suzuki H, Enomoto T, Matsubara D, Oda T, Tsuchiya K
- KMID: 2551282
- Intest Res.
- 2024 Jan;22(1):92-103.
- doi: 10.5217/ir.2023.00105
Background/Aims: Mucosal adaptation of the ileum toward colonic epithelium has been reported in pouchitis in ulcerative colitis (UC); however, the clinical characteristics, endoscopic findings, and outcomes in patients with pouchitis... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of lymphadenectomy on the treatment of endometrial cancer using data from the JSOG cancer registry
-
Saotome K, Yamagami W, Machida H, Ebina Y, Kobayashi Y, Tabata T, Kaneuchi M, Nagase S, Enomoto T, Aoki D, Mikami M
- KMID: 2511568
- Obstet Gynecol Sci.
- 2021 Jan;64(1):80-89.
- doi: 10.5468/ogs.20186
Objective Regional lymph node (LN) dissection is a standard surgical procedure for endometrial cancer, but there is currently no clear consensus on its therapeutic significance. We aimed to determine the... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database
-
Ueda A, Watari H, Mandai M, Fukuhara S, Sugitani Y, Ogino K, Kamijima S, Enomoto T
- KMID: 2537969
- J Gynecol Oncol.
- 2022 Nov;33(6):e78.
- doi: 10.3802/jgo.2022.33.e78
Objective To assess the incidence of bevacizumab-associated gastrointestinal (GI) perforation during first-line treatment of patients with ovarian, fallopian tube, or peritoneal cancer receiving neoadjuvant chemotherapy (NAC) in Japanese real-world clinical practice. Methods A... -
- CITED
-
- Close
- SHARE
-
- Close
- A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma
-
Yamagami W, Nagase S, Takahashi F, Ino K, Hachisuga T, Mikami M, Enomoto T, Katabuchi H, Aoki D
- KMID: 2511956
- J Gynecol Oncol.
- 2020 Jul;31(4):e45.
- doi: 10.3802/jgo.2020.31.e45
Objective: International Federation of Gynecology and Obstetrics (FIGO) staging for ovarian, fallopian tube, and peritoneal cancers was revised in 2014. The aim of this study is to clarify whether the... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052)
-
Asano H, Oda K, Yoshihara K, Ito YM, Matsumura N, Shimada M, Watari H, Enomoto T
- KMID: 2537899
- J Gynecol Oncol.
- 2022 Jul;33(4):e55.
- doi: 10.3802/jgo.2022.33.e55
Background Poly (adenosine diphosphate)-ribose polymerase (PARP) inhibitors for tumors with homologous recombination deficiency (HRD), including pathogenic mutations in BRCA1/2, have been developed. Genomic analysis revealed that about 20% of uterine leiomyosarcoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
-
Kobayashi Y, Masuda K, Hiraswa A, Takehara K, Tsuda H, Watanabe Y, Oda K, Nagase S, Mandai M, Okamoto A, Yaegashi N, Mikami M, Enomoto T, Aoki D, Katabuchi H, Working Group on Clinical Practice for Cancer Genomic Medicine and HBOC, Japan Society of Gynecologic Oncology
- KMID: 2537910
- J Gynecol Oncol.
- 2022 Sep;33(5):e61.
- doi: 10.3802/jgo.2022.33.e61
Objective The practices pertaining to hereditary breast and ovarian cancer (HBOC) in Japan have been rapidly changing owing to the clinical development of poly(ADP-ribose) polymerase inhibitors, the increasing availability of companion... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study
-
Machida H, Matsuo K, Oba K, Aoki D, Enomoto T, Okamoto A, Katabuchi H, Nagase S, Mandai M, Yaegashi N, Yamagami W, Mikami M
- KMID: 2536009
- J Gynecol Oncol.
- 2022 Jan;33(1):e3.
- doi: 10.3802/jgo.2022.33.e3
Objective Associations between hospital treatment volume and survival outcomes for women with 3 types of gynecologic malignancies, and the trends and contributing factors for high-volume centers were examined. Methods The Japan Society of... -
- CITED
-
- Close
- SHARE
-
- Close
- The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG
-
Kondo E, Tabata T, Suzuki N, Aoki D, Yahata H, Kotera Y, Tokuyama O, Fujiwara K, Kimura E, Terauchi F, Sumi T, Okamoto A, Yaegashi N, Enomoto T, Sugiyama T
- KMID: 2512059
- J Gynecol Oncol.
- 2020 Nov;31(6):e94.
- doi: 10.3802/jgo.2020.31.e94
Objective: In this study we sought to investigate the clinical factors that affect postprogression survival (PPS) in patients with recurrent or persistent clear cell carcinoma (CCC). We utilized the JGOG3017/Gynecological Cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Asian Society of Gynecologic Oncology International Workshop 2018
-
Kong TW, Ryu HS, Kim SC, Enomoto T, Li J, Kim KH, Shim SH, Wang PH, Therasakvichya S, Kobayashi , Lee M, Shi T, Lee SW, Mikami M, Nagase S, Lim MC, Wang J, Wilailak S, Kim SW, Hong SH, Tan DS, Mandai M, Chang SJ, Huang RY, Ushijima K, Lee JY, Chen X, Ochiai K, Lee TS, Yang B, Kalam F, Lv Q, Ahmad MF, Yaznil MR, Modi KB, Manopunya , Jeong DH, Lertkhachonsuk Aa, Chung HH, Watari H, Jeon S
- KMID: 2457142
- J Gynecol Oncol.
- 2019 Mar;30(2):e39.
- doi: 10.3802/jgo.2019.30.e39
The Asian Society of Gynecologic Oncology International Workshop 2018 on gynecologic oncology was held in the Ajou University Hospital, Suwon, Korea on the 24th to 25th August 2018. The workshop... -
- CITED
-
- Close
- SHARE
-
- Close
